The expression of CCT5 in ovarian cancer, colon cancer, clear cell RCC, clear cell RCC (extended), UCEC, lung adenocarcinoma, lung squamous cell carcinoma, and head and neck squamous carcinoma was significantly higher than in normal samples. This evidence concerns the gene CCT5 and lung adenocarcinoma.